Liver Diseases Alcoholic clinical trials

Explore recruiting liver diseases alcoholic clinical trials.

Recruiting liver diseases alcoholic studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Liver Diseases Alcoholic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults with Alcohol-related Liver Disease (ALD)

Denmark, Germany, Sweden, France, Spain, Italy +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Liver Diseases Alcoholic trials by city

Liver Diseases Alcoholic clinical trials

Recruiting liver diseases alcoholic studies right now

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

Pyramidal Versus Continuous Training Effects on Fatty Liver

Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD

Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise

Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Effects of VLCKD in Metabolic Syndrome

Also recruiting in Europe

A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults with Alcohol-related Liver Disease (ALD)

Liver Diseases Alcoholic trials by city

Other conditions